Does Chanca Piedra Work? A Practical Look at the Evidence

Affiliate Disclosure

This is a contributed post.

Does chanca piedra work? That question pops up when someone wants a simple, natural option for kidney stones or “gravel” symptoms. Chanca piedra is the common name for Phyllanthus niruri, a plant used traditionally across parts of South America and Asia. You may also see it marketed as stone breaker.

This article explains what research in humans actually shows, what it does not prove, and how to think about it like a cautious professional: as a potential supportive tool, not a guaranteed fix.

---

What is chanca piedra, exactly?

Chanca piedra usually refers to Phyllanthus niruri (sometimes related Phyllanthus species are used, which matters). In the supplement market, products can vary a lot: whole herb powder, extracts, teas, and blends. That variability is one of the main reasons results are inconsistent.

Key terms you’ll see in studies and clinical discussions:

• Urolithiasis (urinary stones)

• Nephrolithiasis (kidney stones)

• Calcium oxalate stones (the most common type)

• Hyperoxaluria / hyperuricosuria (high oxalate or uric acid in urine)

---

Does chanca piedra work for kidney stones in humans?

The honest answer: it might help in specific situations, but the human evidence is limited and not uniform.

When people say “work,” they usually mean one of three things:

1. Helps reduce stone size or number

2. Helps pass stones faster or with less discomfort

3. Helps reduce risk factors for forming new stones

Human studies suggest possible benefits in #1 and #3, especially for small stones and for urinary chemistry that relates to stone risk.

What a meta-analysis found

A systematic review and meta-analysis that included two controlled human studies reported a modest reduction in stone burden, including:

• Decrease in mean stone size (standardized mean difference around -0.39, with a statistically significant result)

• Decrease in stone number (standardized mean difference around -0.38, also statistically significant)

That sounds promising, but the same paper stresses a core limitation: small total sample size and few clinical trials. In other words, signal may exist, but confidence is still not high.

What a single-arm clinical study reported

One prospective study tracked people with kidney stones and found:

• Average stones per patient dropped from about 3.2 to 2.0 over the study period

• Subgroups showed decreases in urinary oxalate and uric acid

• No major changes in common blood markers were noted

This supports the idea that chanca piedra could influence stone-related urinary factors. However, a single-arm design cannot rule out confounders, regression to the mean, or differences in hydration and diet during follow-up.

What a small interventional study suggested about “who benefits”

A study using a Phyllanthus niruri extract combined with magnesium and vitamin B6 reported outcomes that depended heavily on stone size and location:

• About 25% of patients became stone-free after 3 months

• Stones ≤ 3 mm were far more likely to clear

• Across measured stones, 40% were absent on follow-up imaging

• Average stone size reduction among remaining stones was about 1.7 mm

This study also included additional ingredients, so it does not isolate chanca piedra alone. Still, it aligns with a practical pattern: small stones may have a better chance to improve, while larger stones often do not.

---

What “work” can realistically mean for chanca piedra

If you want realistic expectations, think in terms of probabilities and mechanisms, not miracles.

It may help by changing urine chemistry

Human data suggest it can shift urinary factors linked to stones, including oxalate and uric acid in certain subgroups, and may increase urinary magnesium or potassium. These changes can matter because stone formation is strongly influenced by what’s concentrated in urine.

It may affect crystallization behavior (mostly preclinical support)

Reviews describe potential effects on calcium oxalate crystallization and aggregation. That line of evidence is mostly mechanistic and preclinical, but it supports why researchers even bother testing it in humans.

It is not a substitute for urgent care or proven therapies

If a stone is obstructing urine flow, causing fever, severe persistent pain, or kidney function changes, “natural options” are not the priority. That situation needs clinical evaluation.

---

How does chanca piedra compare to what guidelines recommend?

It helps to compare it against standard, evidence-based prevention and supportive care.

Table 1 — Evidence strength: prevention and symptom support

Approach	What it targets	Evidence base	Practical takeaway
High fluid intake (goal urine ≥ 2.5 L/day)	Dilutes stone-forming factors	Strong guideline recommendation	Most reliable baseline habit
Medical expulsive therapy (selected cases)	Helps pass distal ureter stones	Guideline-supported in specific stone sizes	Often used when appropriate
Diet changes (based on stone type)	Lowers recurrence risk	Guideline-supported	Needs personalization
Chanca piedra (Phyllanthus niruri)	Stone burden / urine chemistry	Limited human trials; mixed	Possible adjunct, not a guarantee

Statistical block: guideline hydration target

A major urology guideline recommends fluid intake sufficient to produce at least 2.5 liters of urine per day for stone formers. That is one of the highest-impact changes most people can actually implement consistently.

---

Why the evidence looks mixed

Even good herbs can look inconsistent when the real-world inputs are messy.

Key reasons:

• Different species and plant parts used (Phyllanthus is a large genus)

• Different extract types (water infusion vs standardized extract)

• Different dosages and durations

• Different stone composition (calcium oxalate vs uric acid vs others)

• Different outcomes measured (symptoms vs imaging vs urine chemistry)

In practice, many “success stories” mix several changes at once: more hydration, fewer sugary drinks, diet adjustments, and time.

---

Is chanca piedra safe?

Safety data in humans is not as deep as you’d want for something marketed everywhere, but several sources report generally tolerable short-term use in studied contexts.

Important points:

• Some studies report minimal changes in routine blood measures during the study window.

• Long-term safety is less certain, especially for concentrated extracts taken continuously.

What side effects get reported?

Reports include GI upset and urinary discomfort in some users. These are not unique to chanca piedra, but they matter if you already feel irritated from a stone episode.

Who should be extra cautious?

This is where “professional tone” matters, because risks come from interactions, not from the herb being inherently “toxic.”

Be cautious if you:

• Take blood pressure medications (possible additive lowering effect)

• Take diabetes medications (possible additive glucose-lowering effect)

• Take lithium (diuretic-like effects may alter lithium levels)

• Take anticoagulants or antiplatelets (bleeding risk is a general concern with some botanicals)

• Are pregnant or breastfeeding (insufficient safety data)

If you’re on prescription meds, the safest approach is to ask a clinician or pharmacist to check interaction risk with your exact regimen.

---

How to use the evidence to make a smart decision (without overpromising)

You can treat chanca piedra as an experiment with guardrails:

• It may support stone-related urinary factors.

• It may help modestly with stone burden in limited studies.

• It should not delay evaluation when symptoms are serious.

Table 2 — When chanca piedra is more vs less plausible

Scenario	Plausibility	Why
Small kidney stones (around a few mm)	Higher	Studies show better outcomes with small stones
You’re also improving hydration	Higher	Hydration is a strong baseline, lowers confounding
Large stones (≥ 6 mm)	Lower	Studies suggest limited change; often needs clinical plan
Fever, infection signs, severe obstruction pain	Not appropriate	Needs urgent medical evaluation

---

Checklist: a cautious “beginner protocol” mindset

Use this checklist as a decision filter, not medical advice.

• Confirm what you’re dealing with (symptoms alone are not a diagnosis).

• If pain is severe, persistent, or you have fever, seek urgent care.

• If you choose a product, look for:

  • clear botanical name (Phyllanthus niruri)

  • dose and serving transparency

  • third-party testing signals (when available)

• Track:

  • hydration and urine color

  • symptoms and timing

  • imaging follow-up when clinically appropriate

• Avoid stacking multiple new supplements at once.

• Reassess after a defined window, not indefinitely.

---

Does Chanca Piedra Work | FAQ

Does chanca piedra work for kidney stones?

Human studies suggest possible modest benefit for stone burden or urinary risk factors, but evidence is limited and not definitive.

How long does it take to work if it works?

Studies commonly evaluate 8–12 weeks. Outcomes vary by stone size, location, and what else you change.

Is chanca piedra proven to dissolve stones?

No. Research suggests potential changes in stone burden and urine chemistry, but it is not proven as a stone “dissolver” in general use.

Can I use it with tamsulosin or other stone meds?

Ask a clinician. Combining products can increase side effect risk, and you want a clear plan rather than guessing.

What is the most effective non-drug step for prevention?

Consistent hydration aiming for urine output around 2.5 L/day is a top guideline-backed step.

Which stones is it most relevant for?

Most discussion focuses on calcium oxalate stones because they are common, but you should confirm stone type when possible.

---

Glossary

• Phyllanthus niruri: The botanical name commonly linked to chanca piedra.

• Urolithiasis: Stones anywhere in the urinary tract.

• Nephrolithiasis: Stones in the kidney.

• Ureteral stone: A stone moving through the ureter toward the bladder.

• Calcium oxalate: The most common stone composition type.

• Hyperoxaluria: High oxalate in urine; raises calcium oxalate stone risk.

• Hyperuricosuria: High uric acid in urine; can increase stone risk.

• CT scan (non-contrast): A standard imaging method to confirm stone size and location.

• Medical expulsive therapy (MET): Meds used to support stone passage in selected cases.

---

Conclusion

Chanca piedra may help some people, especially with small stones or certain urinary risk factors, but the clinical evidence remains limited. If you use it, use it as an adjunct alongside proven basics like hydration and proper evaluation.

---

Resources

1. Dhawan S, Olweny EO. “Phyllanthus niruri (stone breaker) herbal therapy for kidney stones; a systematic review and meta-analysis of clinical efficacy…” Canadian Journal of Urology. 2020. https://pubmed.ncbi.nlm.nih.gov/32333735/

2. Dhawan S, Olweny EO. PDF full text. Canadian Journal of Urology. 2020. https://canjurol.com/html/subscriber/Spdf/V27I02/Cdn_JU27-I2_07_DrOlweny_S.pdf

3. Pucci ND et al. “Effect of Phyllanthus niruri on metabolic parameters of patients with kidney stone…” 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6092661/

4. Cealan A et al. “Evaluation of the efficacy of Phyllanthus niruri standardized extract combined with magnesium and vitamin B6…” 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6510356/

5. American Urological Association. “Kidney Stones: Medical Management Guideline” (urine volume target ≥2.5 L/day). Updated page accessed 2026. https://www.auanet.org/guidelines-and-quality/guidelines/kidney-stones-medical-mangement-guideline

6. European Association of Urology. “EAU Guidelines on Urolithiasis” (medical expulsive therapy summary). Updated page accessed 2026. https://uroweb.org/guidelines/urolithiasis/chapter/guidelines

7. Hughes T et al. “Guideline of guidelines for kidney and bladder stones.” 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7731951/

Related:

• The 11 Best Workout Recovery Strategies

• The Minimum Effective Dose Of Protein Intake

• Post-Surgical Recovery Milestones For At-Home Patients